Efficacy of a Comprehensive Pain Rehabilitation Program. A Longitudinal Study. Cognitive-behavioral approach. Mayo Clinic Pain Rehabilitation Center



Similar documents
Transitioning a Pain Program Away From Chronic Opioid Prescribing

Objectives. Significant Costs Of Chronic Pain. Pain Catastrophizing. Pain Catastrophizing. Pain Catastrophizing

Comprehensive Pain Rehabilitation Center

Opioid detoxification slow. Charles Brooker Pain Medicine, Royal North Shore Hospital Sydney

Pediatric Pain Rehabilitation Program (PPRC)

Medical marijuana for pain and anxiety: A primer for methadone physicians. Meldon Kahan MD CPSO Methadone Prescribers Conference November 6, 2015

PRIMARY CARE & HEALTH SERVICES SECTION

THE COMMONWEALTH OF MASSACHUSETTS Department of Industrial Accidents

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy

Opioid Treatment Guidelines. Denis G. Patterson, DO University of Nevada, Reno 7/15/2015

The Mainz Pain Staging System (MPSS) Instructions for use of the MPSS-Scoring Form

IMR ISSUES, DECISIONS AND RATIONALES The Final Determination was based on decisions for the disputed items/services set forth below:

PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain

A systematic review of focused topics for the management of spinal cord injury and impairment

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC


03/20/12. Recognize the right of patients to appropriate assessment and management of pain

Prior Authorization Guideline

Pain, Addiction & Methadone

Patients are still addicted Buprenorphine is simply a substitute for heroin or

Tension-type headache Non-pharmacological and pharmacological treatment

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians

AMERICAN ACADEMY OF PAIN MANAGEMENT Prescribing Issue

Alcohol and Drug. A Cochrane Handbook. losief Abraha MD. Cristina Cusi MD. Regional Health Perugia

Economic aspects of Spinal Cord Stimulation (SCS)

PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications

OPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School

Objectives. Pain Management Knowing How To Help Yourself. Patients and Family Requirements. Your Rights As A Consumer

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN

INDUSTRIAL REHABILITATION CHRONIC PAIN / FIBROMYALGIA TREATMENT PROGRAMS

Tension Type Headaches

Primary Care Behavioral Interventions for Pain and Prescription Opioid Misuse

Test Content Outline Effective Date: June 9, Pain Management Nursing Board Certification Examination

Annual Outcome Comparison Report-Source One/Village Jan 1, thru Dec 31, 2013

Medical Malpractice Treatment Alprazolam benzodiazepine - A Case Study

COMPREHENSIVE PAIN REHABILITATION CENTER OUTPATIENT PROGRAMS

CHRONIC PAIN SYNDROME AND EVIDENCE-BASED TREATMENT

PAIN MANAGEMENT AT UM/SYLVESTER

Tension-type headache Non-pharmacological and pharmacological treatment

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain

Medications for chronic pain

POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics

33 % of whiplash patients develop. headaches originating from the upper. cervical spine

Assessment and Management of Chronic Pain Guideline Summary

Interdisciplinary Care in Pediatric Chronic Pain

Treatment of Chronic Pain: Our Approach

indicates that the relationship between psychosocial distress and disability in patients with CLBP is not uniform.

Michigan Board of Nursing Guidelines for the Use of Controlled Substances for the Treatment of Pain

Striking a Balance: a provider perspective. kpfeifer@chcf.org

Behavioral Health Medical Necessity Criteria

4/18/14. Background. Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients. Background. Signs and Symptoms of Withdrawal

Lora McGuire MS, RN Educator and Consultant Barriers to effective pain relief

Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain

Comprehensive Pain Rehabilitation Center

Pain is a common symptom reported

COUNTY OF LOS ANGELES - DEPARTMENT OF MENTAL HEALTH OFFICE OF THE MEDICAL DIRECTOR. 3.4 PARAMETERS FOR THE USE OF ANXIOLYTIC MEDICATIONS October 2014

August Is Palliative Care and Cancer Pain Awareness Month

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

How To Cover Occupational Therapy

UW MEDICINE PATIENT EDUCATION. Your Care Team. Helpful information

Step 4: Complex and severe depression in adults

Benzodiazepine Detoxification and Reduction of Long term Use

Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION

Prior Authorization Guideline

Treating Addiction in Chronic Pain Patients A Clinical Journey. Brad Anderson, MD Chief, Department of Addiction Medicine Kaiser Permanente Northwest

Behavioral and Physical Treatments for Tension-type and Cervicogenic Headache

BENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM

Cocaine Dependence and Psychotherapy

How To Manage Prescription Drug Costs In Workers Compensation

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998

DEPARTMENT OF PSYCHIATRY Centre Street Boston, MA 02130

Knee Pain/Osteoarthritis: Occupational Therapy Approaches

7. In applying the principles of pain treatment, what is the first consideration?

ROUNDTABLE DISCUSSION

Whiplash and Cervical Spine Disorders: Evaluation and Management

General Hospital Information

Naltrexone and Alcoholism Treatment Test

DSM V criteria. Defining Opioid Use Disorder (Addiction)

Why are antidepressants used to treat IBS? Some medicines can have more than one action (benefit) in treating medical problems.

Behavioral Health Medical Necessity Criteria

Chronic Pain Management when to involve the Chronic Pain specialist and what can we offer

MEDICATION ABUSE IN OLDER ADULTS

EPIDEMIOLOGY OF OPIATE USE

A Guide to the Rehabilitation in Växjö

The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool

RESIDENTIAL TREATMENT PROGRAM REVIEW

How To Write An Opiate Prescription Guideline

3/10/2015. SPEAKER NAME AND CREDENTIALS: Roberta Goff, MSN Ed, RN-BC, ACNS-BC, ONC

Managing Chronic Pain

Early intervention to prevent the development of long term disability post spinal surgery

Acceptance and Commitment Therapy (ACT) and Chronic Pain

Guidelines for the use of unlicensed and off label medication within NHS Fife Addiction Services

TREATMENT-RESISTANT DEPRESSION AND ANXIETY

KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE

Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients

Blueprint for Prescriber Continuing Education Program

ISSUED BY: TITLE: ISSUED BY: TITLE: President

Health Care Service System in Thailand for Patients with Alcohol Use Disorder

CHRONIC PAIN MANAGEMENT PRODUCTS & SERVICES: A MARKET ANALYSIS TABLE OF CONTENTS

Transcription:

Efficacy of a Compreheive Pain Rehabilitation Program with Opioid Withdrawal: A Longitudinal Study Connie Luedtke, MA, RN-BC Mayo Clinic Pain Rehabilitation Center Luedkte.connie@mayo.edu www.mayoclinic.org/pain-rehabilitation-center-rst/ Mayo Clinic Pain Rehabilitation Center Team: MD, PhD, PharmD, CNS, RN, MA, OT, PT Program optio, utilizing a CBT approach 3-week outpatient rehabilitation, adult population 3-week outpatient rehabilitation, adolescent population with inteive family programming Cognitive-behavioral approach Improvement of physical functioning Improved general functional status (ADLs, social, household, recreational) Improved vocational/school functioning Reduction in health care utilization Reduction/discontinuation of opioids, sedativehypnotic and over the counter medicatio Reduction in pain level (not always attainable) 1

Pain 140 (2008) 177-189 Study Design Longitudinal 2 group pre-post design Compared 373 coecutive patients admitted d to Mayo PRC Admission, discharge and 6 month data Compared opioid and non-opioid groups Outcome Measures Multidimeional Pain Inventory (MPI) CES-D Pain Catastrophizing Scale SF-36 2

PRC Patient Characteristics (N=373) Average age 45 years (range 18 to 83) 96% Caucasian 79% female 28% employed Primary Pain Complaint: Back (24%), fibromyalgia (20%), chronic headache or migraine (12%) Average Pain Duration 9.4 years Failed all other treatments Characteristics of Opioid Use Opioid use status: 57% daily opioids Mean Morphine Equivalent dose: 99.0 mg (range 1.0 to 1060 mg/qd) Duration of opioid use: mean, 3.9 years 20% less than one year 65% two or more years 30% five or more years CNCP Patients on Chronic Opioid Therapy No differences in demographic or pain characteristics between opioid group -non-opioid group Pre-treatment: Opioid group reported significantly greater pain severity, and depression than non-opioid group Opioid group used significantly more benzos, muscle relaxants & anticonvulsants than non-opioid group. High levels of pain catastrophizing and debilitation comparable to patients not taking opioids. 3

Post Pain Rehab with Opioid Withdrawal 91% complete 3-week treatment 93% of those on daily opioids tapered completely off by end of treatment Significant reduction in benzo, NSAIDS, muscle relaxants, anticonvulsants, tricyclic antidepressants SSRI use remained the same Duloxetine use increased Patients who tapered off opioids reported: Comparable treatment success at discharge as patients who were not taking opioids. Significant decrease in Pain severity, Life Interference due to pain, Depression, and Pain Catastrophizing (p<.001) Significant increase in Perceived life control, General Activity Level, Health Perception, Physical Functioning, Activities of Daily Living, Social Functioning (p<.001) Pain Severity and Suffering (MPI) S D=10) M ean T-Score (S 60 50 40 30 20 10 0 * ** Pre Post 6 Month Opioid Use on Admission No oopodso opioids on Admission Within Subjects (both groups) * = pre post ** = pre 6 months 4

Depression (CES-D) e Mean Score 35 30 25 20 15 10 5 0 * ** Pre Post 6 Month Opioid Use on Admission No opioids on Admission Within Subjects (both groups) * = pre post **= pre 6 months Physical Functioning (SF-36) D=10) Mean T-Score (S 50 40 30 20 10 0 * ** Pre Post 6 Month Opioid Use on Admission No opioids on Admission Within Subjects (both groups) * = pre post ** = pre 6 months 6-months Post treatment Results were same for patients withdrawn from lowdose (<100 mg; M=39 mg/qd) and high-dose (> 100 mg/qd; M=260 mg/qd) opioids 33 patients (14%) who completed treatment and returned survey were taking opioids Overall, improvements in pain, functioning and mood were maintained six months following treatment even when the majority of patients reported continued abstinence from opioid analgesics 5

Implicatio Opioid induced hyperalgesia could be a reason for greater pre-treatment pain and depression scores for opioid group Cannot infer causal relatiohip due to study methodology Opioid withdrawal did not interfere with rehabilitation Study Limitatio Lack of a control group Subject attrition Self reported data Limited diversity Future studies: Specific pain populatio Conclusion Patients with debilitating chronic pain CAN experience significant and sustained improvement in pain and functioning following pain rehabilitation that incorporates opioid withdrawal. 6

Efficacy of a Compreheive Pain Rehabilitation Program with Opioid Withdrawal: A Longitudinal Study Connie Luedtke, MA, RN-BC Mayo Clinic, Rochester, MN I. Overview of Mayo Clinic Multidisciplinary Pain Rehabilitation Program II. Efficacy of Cognitive Behavioral Therapy IASP 10th World Congress (2005) Cognitive Behavioral Therapy is as effective for a heterogeneous group of chronic pain sufferers as any published therapy for any specific type of pain Turk (2002) Review of compreheive pain rehabilitation programs more cost effective than implantation of spinal cord stimulators, intraspinal drug delivery systems/surgery significantly greater reduction in medication use, and health care utilization significantly greater increases in functional activities, return to work, closure of disability claims substantially fewer iatrogenic coequences/adverse events APS Task Force Review (2006) - Compared to different treatment modalities including the standard medical approach or medication management, Multidisciplinary Pain Rehabilitation is the only therapeutic approach that has demotrated treatment efficacy and cost-effectiveness for functional restoration and major outcome variables (pain severity, healthcare utilization, medication use, disability claims). III. Chronic Opioid Therapy for Chronic Pain In 1997, APS and AAPM issued statements that opioid therapy for Chronic Non-Cancer Pain is a legitimate medical practice. Minimized concer of addiction, respiratory depression and other side effects, and tolerance 1997-2005 - 90% increase in opioid prescriptio - Money spent on marketing for opioids increased from $11 to $30 billion - Spending on outpatient prescriptio tripled in 10 years (4.2 in 1996 to 13.2 billion in 2006; AHRQ, 2009) What did the Coeus statement REALLY say?? periodic reexamination is warranted to assess the nature of the pain complaint and to eure that opioid therapy is still indicated. Attention should be given to the possibility of a decrease in global function or quality of life as a result of opioid use [1997, p. 3]. Coideration should be given to different treatment modalities, such as a formal pain rehabilitation program, the use of behavioral strategies, the use of noninvasive

techniques, or the use of medicatio, depending upon the physical and psychosocial impairment related to the pain [1997, p. 3]. Efficacy for Chronic Opioid Therapy Six meta-analyses and reviews of randomized, double-blind, placebo-controlled trials of opioids for CNCP Flawed Empirical Efficacy Significant drop out rates/exclusion criteria Very short-term outcomes (avg. 5 weeks!) Lack of clinically significant reduction in pain No documented improvement in functioning Possible publication bias Additional Reaso for Concern Tolerance/Dependence, Addiction Possible Opioid-induced Hyperalgesia Opioids maintained despite decline in functioning and no improvement in pain (fear motivated?) Pain behaviors predict physicia prescriptio IV. Evidence-based practice guidelines for CNCP and opioids Conclusio: ICSI, 2008; Sanders et al., 2005 Controlled opioid trials have limited applicability to the long-term use of opioids in clinical practice Clinicia should coider other forms of treatment including rehabilitation approach that emphasizes self-management and functional restoration V. Study Description (See power point) VI. Patient Outcomes (See power point) VII. Conclusio (See power point) VIII. Additional Resources Mayo Clinic Guide to Pain Relief by Barbara Bruce, PhD and W. Michael Hooten, MD (2008) Available: http://bookstore.mayoclinic.com Psychological Approaches to Pain Management, Second Edition: A Practitioner's Handbook by Dennis C. Turk and Robert J. Gatchel (Editors) (2002) ISBN: 1572306424 Managing Chronic Pain: A Cognitive-Behavioral Therapy Approach by John Otis (2007) Therapist Guide, ISBN13: 9780195329162; Workbook, ISBN13: 9780195329179 Managing Pain Before It Manages You by Margaret Caudill, Herbert Beon (2001) ISBN-13: 9781572307186 Manage Your Pain by Michael Nicholas, Allan Molloy, Lois Tonkin, Lee Beeston and Charles Pither (2006) ISBN-13: 9780285636798